Alongside Uni Venture, a venture capital arm of Bawag that works closely with Innovationsagentur, in the round were Buschier, Fides and Hybag.
Innovacell Biotechnologie, an Austria-based biotechnology company, has raised €8.3m ($11m) from a consortium including Bawag’s university spin-off fund. Alongside Uni Venture, a venture capital arm of Bawag that works closely with Innovationsagentur, in the round were Buschier, Fides and Hybag. In September 2010, Innovacell raised €4.3m from undisclosed investors.
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
